N-((S)-3-((1R,3R,5S)-3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1]Octan-8-yl)-1-(4-methylthiophen-2-yl)-propyl)-1-(methylsulfonyl)piperidine-4-carboxamide

ID: ALA5204027

Chembl Id: CHEMBL5204027

PubChem CID: 168293785

Max Phase: Preclinical

Molecular Formula: C28H44N6O3S2

Molecular Weight: 576.83

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1csc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)c1

Standard InChI:  InChI=1S/C28H44N6O3S2/c1-18(2)27-31-30-20(4)34(27)24-15-22-6-7-23(16-24)33(22)13-10-25(26-14-19(3)17-38-26)29-28(35)21-8-11-32(12-9-21)39(5,36)37/h14,17-18,21-25H,6-13,15-16H2,1-5H3,(H,29,35)/t22-,23+,24-,25-/m0/s1

Standard InChI Key:  IEPXWDCXYAYQPU-NDBXHCKUSA-N

Alternative Forms

  1. Parent:

    ALA5204027

    ---

Associated Targets(Human)

CCR5 Tclin C-C chemokine receptor type 5 (5640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TZM (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 576.83Molecular Weight (Monoisotopic): 576.2916AlogP: 4.17#Rotatable Bonds: 9
Polar Surface Area: 100.43Molecular Species: BASEHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.29CX Basic pKa: 9.12CX LogP: 1.66CX LogD: -0.06
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.48Np Likeness Score: -1.44

References

1. Xie X, Zheng YG, Chen H, Li J, Luo RH, Chen L, Zheng CB, Zhang S, Peng P, Ma D, Yang LM, Zheng YT, Liu H, Wang J..  (2022)  Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability.,  65  (24.0): [PMID:36472561] [10.1021/acs.jmedchem.2c01383]

Source